MET and cancer: Fusion pairs were also identified in colon (CAPZA2-MET and MET-MET), lung (PIK3CA-TBL1XR1 and RET-NCOA4) and pancreatic (FNDC3B-PIK3CA and TBL1XR1-PIK3CA) cancers (S6 Table).